Table 2.
Percentage of subjects with anti-HBs titers 0–9, 10–99, 100–999 and ≥1000 mIU/mL and GMC at twelve years after the primary series, stratified by immunization schedule.
| Immunization schedule | N | Subjects (%) anti-HBs titers (mIU/mL) |
Seroprotection Subjects(anti-HBs titers ≥10 mIU/ml)(%) | GMC(95%CI, mIU/ml) | ||||
|---|---|---|---|---|---|---|---|---|
| 0- | 10- | 100- | ≥1000 | |||||
| Total | 396 | 147(37.12) | 165(41.67) | 74(18.69) | 10(2.53) | 249(62.88) | 20(16–24) | |
| 0–1-6 | 202 | 57(28.22) | 92(45.54) | 47(23.274) | 6(2.97) | 145(71.78) | 31(24–41) | |
| 0–6 | 194 | 90(46.39) | 73(37.63) | 27(13.92) | 4(2.06) | 104(53.61) | 12(9–17) | |
| Statistical value | 15.69 | 20.82 | ||||||
| P value | <0.001 | <0.001 | ||||||